Innova Captab
707.65
+0.55(+0.08%)
Market Cap₹4,049.52 Cr
PE Ratio30.58
IndustryHealthcare
Company Performance:
1D+0.08%
1M-3.48%
6M-22.42%
1Y-29.74%
5Y+30.71%
View Company Insightsright
More news about Innova Captab
16Oct 25
Innova Captab Faces ₹15.81 Crore GST Demand Over Excess Input Tax Credit Refund Claims
Innova Captab Limited received a Show Cause cum Demand Notice from CGST Commissionerate, Shimla, for alleged excess refund claims of Input Tax Credit. The notice covers May 2020 to March 2024, demanding ₹15,81,37,255.40 with additional interest and penalties. The company is accused of incorrectly applying for refunds under Rule 89(4) instead of Rule 89(4B) of CGST Rules. Innova Captab denies merit in the notice and plans to submit a defense within 30 days.
 no imag found
07Aug 25
Innova Captab Reports Robust Q1 Results with 19% Revenue Growth
Innova Captab announced robust Q1 financial results, with revenue increasing 19% YoY to ₹351.50 crore. EBITDA grew 28% to ₹56.60 crore, and PAT rose 5% to ₹31.00 crore. The CDMO Services segment revenue reached ₹249.50 crore, up 8% YoY, while Branded Generics revenue surged 59% to ₹102.10 crore. The company's new Jammu facility gained momentum, contributing to overall growth. Management expressed confidence in sustainable growth and long-term value creation.
 no imag found
19May 25
Innova Captab Reports Strong Q4 Performance with Improved EBITDA and Revenue Growth
Innova Captab's Q4 financial results show significant growth. Revenue increased by 19.77% to 3.15 billion ₹, while EBITDA grew by 25.20% to 477.00 million ₹. The EBITDA margin improved by 65 bps to 15.16%. Net profit saw a modest 3.14% increase to 296.00 million ₹. The company's performance indicates strong market demand and improved operational efficiency.
 no imag found
Innova Captab
707.65
+0.55
(+0.08%)
1 Year Returns:-29.74%
Industry Peers
Sun Pharmaceutical
1,695.10
(-0.44%)
Divis Laboratories
6,024.50
(-1.91%)
Torrent Pharmaceuticals
3,939.00
(-0.94%)
Cipla
1,330.00
(-0.25%)
Dr Reddys Laboratories
1,241.20
(-0.30%)
Lupin
2,173.70
(-2.02%)
Zydus Life Science
888.15
(-1.86%)
Mankind Pharma
2,060.20
(-0.97%)
Aurobindo Pharma
1,191.00
(+0.80%)
Alkem Laboratories
5,684.00
(+0.38%)